Skip to content

Melatonin in patients with Burning Mouth syndrome

Comparison of the Effectiveness Of Melatonin in patients with Burning Mouth syndrome

Status
Recruiting
Phases
Phase 2
Study type
Interventional
Source
IRCT
Registry ID
IRCT20141220020377N3
Enrollment
30
Registered
2019-08-14
Start date
2019-09-23
Completion date
Unknown
Last updated
2019-10-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Burning Mouth Syndrome. Burning Mouth Syndrome

Interventions

Intervention 1: Intervention group: In intervention group patients will use Melatonin Tab 3 Mg (Iran Construction of A-lHavi Company) 4 times a day for 5 month. Intervention 2: Control group: In Contr

Sponsors

Zahedan University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: Burning mouth at all times Lack of Systemic Disease and chronic medication Patients over 18 years of age No use of Smoking Lack of oral lesion

Exclusion criteria

Exclusion criteria: Elderly people with glaucoma Those who take aspirin or heparin or warfarin Those who take acetonol and metoprolol because they reduce the effect of melatonin Patients with epilepsy

Design outcomes

Primary

MeasureTime frame
Level of Sensation. Timepoint: The First Visit, 8 weeks Later, 4 weeks Later,4 weeks Later, 8 weeks Later. Method of measurement: Visual Analogue Scale.;Average sleep disorder. Timepoint: The First Visit, 24 weeks Later. Method of measurement: Questionnaire.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactDr.Tahereh Nosratzehi

Zahedan University of Medical Sciences

Nosratzehi@zaums.ac.ir+98 54 3401 3041

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026